Impact of Chronic Kidney Disease on Decision Making and Management in Transcatheter Aortic Valve Interventions

Publication date: September 2019Source: Canadian Journal of Cardiology, Volume 35, Issue 9Author(s): Mark Hensey, Dale J. Murdoch, Janarthanan Sathananthan, David A. Wood, John G. WebbAbstractThe coexistence of chronic kidney disease (CKD) and severe aortic stenosis (AS) is common, and the prevalence of both is rising. The 2 conditions are inherently linked in that significant CKD may accelerate the development of AS and severe AS may result in deteriorating kidney function. The volume of and indications for transcatheter aortic valve implantation (TAVI) procedures are ever-increasing, and there are many challenges that need to be considered in patients with concomitant severe AS and CKD being assessed for TAVI. Throughout the process of working these patients up for definitive management of their valvular heart disease, the presence of CKD impacts on diagnostic investigations, treatment decisions, and therapeutic interventions. Herein we review the current literature regarding TAVI in patients with CKD focusing on the decision-making process and specific risks involved in TAVI and CKD. We also provide specific practical strategies to best manage this challenging patient cohort.RésuméLa coexistence de la maladie rénale chronique (MRC) et de la sténose aortique (SA) est fréquente, et la prévalence de ces 2 maladies augmente. Les 2 maladies sont intrinsèquement liées, en ce sens qu’une MRC importante peut accélérer le développement de la SA, et qu’une SA grave pe...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research